Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) anticoagulant, today highlighted a key opinion leader presen ...

DeBakey Department of Surgery at Baylor College of Medicine Previous studies ... levels of OxPhos in white blood cells could help predict the risk of stroke after CF-LVAD implantation," said first ...

High blood pressure is linked to a myocardial anatomical change called LVH. Learn how to offset left ventricular thickening ...

The findings suggest that changes of OxPhos proteins in white blood cells could help predict new strokes after cardiac assist device implantation.

Heart muscle cells grown from stem cells show promise in monkeys with a heart problem that typically results from a heart ...

Barring unforeseen rivals, Imricor will have a 100 per cent share of the MRI-guided cardiac catheter ablation market, writes ...

The following is a summary of “Changes in portal pulsatility index induced by a fluid challenge in patients with haemodynamic ...

Systolic congestive heart failure is when the left side of the heart weakens, and the heart can't pump effectively. It can cause a variety of symptoms.

Ventricular Assist Devices (VADs ... 2 The devices are implanted into the body, meaning open heart surgery is needed to install them. 3,4 The power supplied to VADs is also subject to ...

A new technology known by doctors as “heart in a box” is being used at Sharp Memorial Hospital in San Diego and it is helping ...

Discover new research that reveals the benefit of early TAVR in patients with asymptomatic severe aortic stenosis.